Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:5:p15
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 5 (pt 15/22)
Character Range: 290069–293040

preparations containing 20% or less of monoethanolamine except:
 (a) when included in Schedule 4; or
 (b) in preparations containing 5% or less of monoethanolamine.
MORANTEL in preparations containing 25% or less of morantel except in preparations containing 10% or less of morantel.
MOXIDECTIN:
 (a) in preparations for external use for the treatment of animals other than cats and dogs, containing 0.5% or less of moxidectin; or
 (b) in preparations for external use for the treatment of cats and dogs, containing 25 mg or less of moxidectin packed in single dose tubes; or
 (c) for internal use for the treatment of animals:

          (i) in divided preparations for dogs, containing 250 micrograms or less of moxidectin per dosage unit in a pack containing six or less dosage units; or

          (ii) in other preparations containing 2% or less of moxidectin.
MYCLOBUTANIL.
NAA except in preparations containing 25% or less of NAA.
NALED when impregnated in plastic resin strip material containing 20% or less of naled.
NAPTALAM.
NEOSCYTALIDIUM NOVAEHOLLANDIAE except when used as a herbicide in capsule preparations at a concentration of 16 CFU or less per capsule.
NETOBIMIN for the treatment of animals, in preparations containing 12.5% or less of netobimin.
NICOTINIC ACID when packed and labelled for use as an agricultural chemical.
NITRIC ACID (excluding its salts and derivatives) in preparations containing 10% or less of nitric acid (HNO3) except in preparations containing 0.5% or less of nitric acid.
NITROSCANATE for the treatment of animals.
NONANOIC ACID:
 (a) when used in a pesticide; or
 (b) in other preparations except in preparations containing 10% or less of nonanoic acid.
NONOXINOL 9 in preparations containing 25% or less of nonoxinol 9 except:
 (a) when labelled with the statements:

          (i) IRRITANT; and

          (ii) Avoid contact with eyes; or
 (b) in preparations containing 12.5% or less of nonoxinol 9; or
 (c) in preparations for human use.
NORBORMIDE.
NUTMEG OIL except:
 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
 (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 25 mL or less fitted with a restricted flow insert, and labelled with the warning:

           KEEP OUT OF REACH OF CHILDREN; or
 (c) in preparations containing 50% or less of nutmeg oil.
N‑OCTYL BICYCLOHEPTENE DICARBOXIMIDE except in preparations containing 10% or less of N‑octyl bicycloheptene dicarboximide.
N‑(N‑OCTYL)‑2‑PYRROLIDONE in preparations containing 50% or less of:
 (a) N‑(N‑octyl)‑2‑pyrrolidone or preparations containing 50% or less of a mixture of any two or more of N‑(N‑octyl)‑2‑pyrrolidone, N‑methyl‑2‑pyrrolidone; or
 (b) N‑(N‑dodecyl)‑2‑pyrrolidone except